Last updated on August 2019

Post Market Observational Prospective Multi-center Study


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Emphysema
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • All adult patients diagnosed with homogeneous or heterogeneous emphysema who are appropriate for Coil treatment based on the CE-Mark Approved IFU and who have been scheduled for treatment with the RePneu procedure
  • RV of >175% predicted
  • Post bronchodilator FEV1 of 45% predicted.
  • Normal international normalized ratio (INR) in the absence of anticoagulation therapy
  • Participant read, understood and signed the Informed Consent form

Exclusion Criteria:

  • Known uncontrolled pulmonary hypertension defined by systolic RVP >50mmHg
  • Giant bullae > 1/3 lung volume
  • Patients on antithrombotic treatment (except for aspirin) which cannot be stopped 7 days prior to treatment

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.